blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1585739

EP1585739 - SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.02.2012
Database last updated on 14.06.2024
Most recent event   Tooltip24.02.2012No opposition filed within time limitpublished on 28.03.2012  [2012/13]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[2011/16]
Former [2005/42]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis IN 46285 / US
Inventor(s)01 / WEICHERT, Andreas Gerhard
Lilly Forschung GmbH, Essener Strasse 93
22419 Hamburg / DE
02 / BARRETT, David Gene
Lilly Forschung GmbH, Essener Strasse 93
22419 Hamburg / DE
03 / HEUSER, Stefan
Lilly Forschung GmbH, Essener Strasse 93
22419 Hamburg / DE
04 / RIEDL, Rainer
Lilly Forschung GmbH, Essener Strasse 93
22419 Hamburg / DE
05 / TEBBE, Mark Joseph
4985 South Cobblestone Drive
Zionsville, IN 46077 / US
06 / ZALIANI, Andrea
Lilly Forschung GmbH, Essener Strasse 93
22419 Hamburg / DE
 [2005/42]
Representative(s)Burnside, Ivan John
Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU / GB
[N/P]
Former [2011/16]Burnside, Ivan John
Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor Sunninghill Road Windlesham
Surrey GU20 6PH / GB
Former [2005/42]Burnside, Ivan John
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre Erl Wood Manor, Sunnighill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date03815189.016.12.2003
[2005/42]
WO2003US37088
Priority number, dateUS20030438539P06.01.2003         Original published format: US 438539 P
[2005/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004063179
Date:29.07.2004
Language:EN
[2004/31]
Type: A1 Application with search report 
No.:EP1585739
Date:19.10.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 29.07.2004 takes the place of the publication of the European patent application.
[2005/42]
Type: B1 Patent specification 
No.:EP1585739
Date:20.04.2011
Language:EN
[2011/16]
Search report(s)International search report - published on:EP29.07.2004
ClassificationIPC:C07D277/44, C07D285/00, C07D261/14, C07D417/12, C07D417/14
[2005/42]
CPC:
C07D285/135 (EP,US); A61P3/10 (EP); A61P43/00 (EP);
C07D261/14 (EP,US); C07D277/46 (EP,US); C07D277/56 (EP,US);
C07D417/12 (EP,US); C07D417/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2010/23]
Former [2005/42]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:SUBSTITUIERTE ARYLCYCLOPROPYLACETAMIDE ALS GLUCOKINASEAKTIVATOREN[2005/42]
English:SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS[2005/42]
French:ARYLCYCLOPROPYLACETAMIDES SUBSTITUES SERVANT D'ACTIVATEURS DE GLUCOKINASE[2005/42]
Entry into regional phase08.08.2005National basic fee paid 
08.08.2005Designation fee(s) paid 
08.08.2005Examination fee paid 
Examination procedure29.07.2005Amendment by applicant (claims and/or description)
08.08.2005Examination requested  [2005/42]
11.09.2009Despatch of a communication from the examining division (Time limit: M04)
18.01.2010Reply to a communication from the examining division
27.01.2010Despatch of a communication from the examining division (Time limit: M04)
15.04.2010Reply to a communication from the examining division
27.05.2010Communication of intention to grant the patent
17.09.2010Fee for grant paid
17.09.2010Fee for publishing/printing paid
Opposition(s)23.01.2012No opposition filed within time limit [2012/13]
Fees paidRenewal fee
02.01.2006Renewal fee patent year 03
02.01.2007Renewal fee patent year 04
02.01.2008Renewal fee patent year 05
05.01.2009Renewal fee patent year 06
04.01.2010Renewal fee patent year 07
03.01.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0136415  (NOVARTIS AG [CH], et al) [A] 1-23* examples 15-21; claim -; table 1 *;
 [Y]WO0183465  (HOFFMANN LA ROCHE [CH]) [Y] 1-23 * examples 1-10; claim - *;
 [Y]WO0185706  (HOFFMANN LA ROCHE [CH]) [Y] 1-23 * examples 1-40; claim - *;
 [Y]WO0185707  (HOFFMANN LA ROCHE [CH]) [Y] 1-23 * examples 1-17; claim - *
by applicant   - CHEM.PHARM.BULL., (1992), vol. 40, no. 9, pages 2391 - 2398
    - HU; SHENGKUI; NECKERS; DOUGLAS C, J. ORG. CHEM., (1996), vol. 61, pages 6407 - 6415
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.